Skip to main content
Clinical Trials/JPRN-UMIN000049825
JPRN-UMIN000049825
Completed
未知

Evaluation of long-term safety and efficacy after neuroprotective gene therapy with SIV-hPEDF for retinitis pigmentosa - Long-term safety and efficacy after SIV-hPEDF gene therapy for retinitis pigmentosa

Kyushu University0 sites10 target enrollmentJanuary 4, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Retinitis Pigmentosa
Sponsor
Kyushu University
Enrollment
10
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2023
End Date
March 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients whom the investigator determines are not appropriate as research subjects

Outcomes

Primary Outcomes

Not specified

Similar Trials